Recent studies in glioma cells have shown that acetylation‐regulated metabolic enzymes, such as PGAM4, play key roles in modulating glycolytic flux and chemoresistance, reinforcing the notion that lysine acetylation can act as a fine‐tuning mechanism in metabolic control (Lu et al. 2023). This evidence concerns the gene PGAM4 and central nervous system cancer.